Is it simply the dose you're comparing? Not stage of disease, repetition, empty/full stomach, etc?
-
-
Replying to @alexandrosM
Niaee gave between 1-3 doses, didn't specify empty/full, and gave to more advanced disease than Together. It's just this litany of non-issues that no one even tries to pick out for positive trials
1 reply 0 retweets 29 likes -
Replying to @GidMK @alexandrosM
Actually, having had a quick look through the trial protocols, I can't find a single study that found benefits that adhered to all those points you've raised. Does that mean that you believe that there's no evidence for ivermectin working, or are they only issues in Together?
1 reply 0 retweets 39 likes -
Replying to @GidMK
Are you saying that if no study followed all the best practice elements that IVM proponents recommend, then a study that followed none of them is just as valid as one that followed half of them, or one that followed 90% of them?
1 reply 0 retweets 14 likes -
Replying to @alexandrosM
No. I'm saying that there are numerous studies with positive results that you have not criticized for these exact same "flaws"
1 reply 0 retweets 33 likes -
-
Replying to @alexandrosM
Then the Niaee study has the same conjunction. In addition, they gave lower doses of ivermectin. And it is the only RCT to show any statistically significant improvement in mortality for ivermectin
1 reply 0 retweets 32 likes -
Replying to @GidMK @alexandrosM
To put it another way - there's no reasonable argument that in one study a similar regimen resulted in 80% improvement in mortality but in another it's a "flaw" when it resulted in no improvement in mortality. Either it is or isn't an issue
2 replies 0 retweets 41 likes -
Replying to @GidMK
I will remind you that I have said nothing about any other study. I've only written about the TOGETHER study. Everything else you ascribe to me is... strange?
4 replies 0 retweets 15 likes -
Replying to @alexandrosM @GidMK
Isn't this the definition of cherry picking?
1 reply 0 retweets 1 like
Nah it's more goalpost shifting. When the study is positive, no one questions how the drug was given, but for null results suddenly even the tiniest change in the regimen is important (even if that regimen is the same one used in the positive trials)
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.